To disentangle such considerable variability, we used strict inclusion criteria, we adopted the novel WHO diagnostic criteria for gliomas, selecting a unified cohort of IDH1 wild-type glioblastoma and we performed volumetric assessment before any surgical or radio-pharmacological treatment. This evidence concerns the gene IDH1 and glioblastoma.